CompletedNCT03818529
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Studying Hemophilia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- American Thrombosis and Hemostasis Network
- Principal Investigator
- Shannon Carpenter, MD, MSChildren's Mercy Hospital Kansas City
- Enrollment
- 237 enrolled
- Eligibility
- 0-13 years · All sexes
- Timeline
- 2018 – 2022
Study locations (27)
- Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital, Phoenix, Arizona, United States
- Valley Children's Hospital, Madera, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- UCSF Pediatric Hemophilia Treatment Center at Mission Bay, San Francisco, California, United States
- University of Colorado Denver Hemophilia and Thrombosis Center, Aurora, Colorado, United States
- Connecticut Bleeding and Clotting Disorders Center, Farmington, Connecticut, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta/Emory, Atlanta, Georgia, United States
- Augusta University Hemophilia Treatment Center, Augusta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis, Indiana, United States
- Kansas City Regional Hemophilia Center, Kansas City, Kansas, United States
- Maine Hemophilia and Thrombosis Center, Scarborough, Maine, United States
- Boston Hemophilia Center at Children's Hospital of Boston, Boston, Massachusetts, United States
- +12 more locations on ClinicalTrials.gov
Collaborators
CSL Behring · Octapharma · Takeda
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03818529 on ClinicalTrials.govOther trials for Hemophilia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07416604A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia AHoffmann-La Roche
- RECRUITINGPHASE3NCT07545395Safety of KN057 Prophylaxis in Patients With Haemophilia A or BSuzhou Alphamab Co., Ltd.
- RECRUITINGPHASE3NCT04563520SAFE Study: Safety of aPCC Following Emicizumab ProphylaxisEmory University
- RECRUITINGPHASE4NCT07406139PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGNCT06992076Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience RegistryInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGNCT07101926Monitoring of Anti-TFPI in HemophiliaHospices Civils de Lyon
- RECRUITINGPHASE4NCT06941870Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial HypertrophySanofi
- RECRUITINGNCT07314983Long-term Anticoagulation in a Patient With Severe Hemophilia AUniversity Hospital, Strasbourg, France